Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Alison H Banham"'
Autor:
Iva Trenevska, Amanda P Anderson, Carol Bentley, Tasneem Hassanali, Sarah Wiblin, Shaun Maguire, Francesco Pezzella, Alison H Banham, Demin Li
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249967 (2021)
T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoclonal antibodies, to include peptides derived from intracellular proteins that are presented by major histocompatibility complex class I (MHC-I) molec
Externí odkaz:
https://doaj.org/article/9ac3c2ac2ee84090b0a591c24d8b6a6d
Autor:
Lorena Maestre, Juan Fernando García-García, Scherezade Jiménez, Ana Isabel Reyes-García, Álvaro García-González, Santiago Montes-Moreno, Alberto J Arribas, Patricia González-García, Eduardo Caleiras, Alison H Banham, Miguel Ángel Piris, Giovanna Roncador
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0229743 (2020)
Thymocyte selection-associated high-mobility group box (TOX) is a DNA-binding factor that is able to regulate transcription by modifying local chromatin structure and modulating the formation of multi-protein complexes. TOX has multiple roles in the
Externí odkaz:
https://doaj.org/article/8c35e2e4880144ceb30e9bb7209f0a7f
Autor:
Demin Li, Carol Bentley, Jenna Yates, Maryam Salimi, Jenny Greig, Sarah Wiblin, Tasneem Hassanali, Alison H Banham
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0176642 (2017)
Therapeutic monoclonal antibodies targeting cell surface or secreted antigens are among the most effective classes of novel immunotherapies. However, the majority of human proteins and established cancer biomarkers are intracellular. Peptides derived
Externí odkaz:
https://doaj.org/article/31aed34546f24c8981f2b91c934d61df
Autor:
Suketu Patel, Derek Murphy, Eugenia Haralambieva, Zainalabideen A Abdulla, Kah Keng Wong, Hong Chen, Edith Gould, Giovanna Roncador, Chris SR Hatton, Amanda P Anderson, Alison H Banham, Karen Pulford
Publikováno v:
Biomarker Insights, Vol 2014, Iss 9, Pp 77-84 (2014)
Externí odkaz:
https://doaj.org/article/60bdfd2da32c4e59b84844407a07454c
Autor:
Suzanne E Brooks, Stephanie A Bonney, Cindy Lee, Amy Publicover, Ghazala Khan, Evelien L Smits, Dagmar Sigurdardottir, Matthew Arno, Demin Li, Ken I Mills, Karen Pulford, Alison H Banham, Viggo van Tendeloo, Ghulam J Mufti, Hans-Georg Rammensee, Tim J Elliott, Kim H Orchard, Barbara-ann Guinn
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140483 (2015)
Immunotherapy treatments for cancer are becoming increasingly successful, however to further improve our understanding of the T-cell recognition involved in effective responses and to encourage moves towards the development of personalised treatments
Externí odkaz:
https://doaj.org/article/b51049e2ec5048b2b1dd51c43011470d
Autor:
Duncan M Gascoyne, Hayley Spearman, Linden Lyne, Rathi Puliyadi, Marta Perez-Alcantara, Les Coulton, Simon E Fisher, Peter I Croucher, Alison H Banham
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128513 (2015)
Mutations of the forkhead transcription factor FOXP2 gene have been implicated in inherited speech-and-language disorders, and specific Foxp2 expression patterns in neuronal populations and neuronal phenotypes arising from Foxp2 disruption have been
Externí odkaz:
https://doaj.org/article/e960b1051d604d118b097524efe614b3
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
The Notch pathway is increasingly attracting attention as a source of therapeutic targets for cancer. Ligand-induced Notch signalling has been implicated in various aspects of cancer biology; as a consequence pan-Notch inhibitors and therapeutic anti
Externí odkaz:
https://doaj.org/article/447201595f254979aca94dd206954f00
Autor:
Christopher D O Cooper, Charles H Lawrie, Amanda P Liggins, Graham P Collins, Christian S R Hatton, Karen Pulford, Alison H Banham
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23916 (2011)
Peripheral T-cell lymphomas (PTCL) are generally less common and pursue a more aggressive clinical course than B-cell lymphomas, with the T-cell phenotype itself being a poor prognostic factor in adult non-Hodgkin lymphoma (NHL). With notable excepti
Externí odkaz:
https://doaj.org/article/2def748344ba4f329720f34c6db3bad5
Autor:
Helen Sheldon, Wei Zhang, Esther Bridges, Koon Hwee Ang, Salwa Lin, Massimo Masiero, Demin Li, Penny A. Handford, Pat Whiteman, Roman Fischer, Francesca Buffa, Manu Vatish, Alison H. Banham, Adrian L. Harris
Publikováno v:
Journal of Extracellular Biology, Vol 1, Iss 8, Pp n/a-n/a (2022)
Abstract ELTD1/ADGRL4 is an adhesion GPCR with an important role in angiogenesis. We recently identified a role for ELTD1 in wound repair and inflammation. Activation of ELTD1 in endothelial cells results in a type II EMT to myofibroblast‐like cell
Externí odkaz:
https://doaj.org/article/96159b7c9b4047979156dffb776d91ce
Supplementary Figures 1-8 from Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer Therapy
Autor:
Alison H. Banham, Adrian L. Harris, Penny A. Handford, Nicola R. Sibson, James Larkin, Manuel Sarmiento-Soto, Sébastien Serres, Devon Sheppard, Chandramouli Chillakuri, Ji-Liang Li, Ellen Bealing, Jenna Yates, Stephen Stribbling, Sarah Watts, Tasneem Hassanali, Jenny Greig, Carol Bentley, Pat Whiteman, Demin Li, Massimo Masiero
1: JAG1 antibody characterization. 2: antibody inhibition of JAG1 mediated Notch signalling in tumor cell lines. 3: antibody inhibition of JAG1 signalling in vascular cells. 4: antibody inhibition of JAG1 signalling in HUVEC-HUVSMC co-culture. 5: eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d318461372ffb99d014884e8a0f6cac2
https://doi.org/10.1158/1535-7163.22510647
https://doi.org/10.1158/1535-7163.22510647